CClinicalTrials.gg
CompletedNCT04175405Updated Nov 25, 2019

Low-level Laser Therapy With a 635nm Diode Laser on Orthodontic Mini-implants Stability.

An interventional study of Irradiation of implants with 635nm laser in Malocclusion, Angle Class II, sponsored by Wroclaw Medical University. Completed at 1 site in Poland. Per ClinicalTrials.gov, last updated 2019-11-25.

Sponsored by Wroclaw Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Mar 2019, registered Nov 2019).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Sex
All
01

Study summary

The study aimed to clinically estimate an influence of a 635nm diode laser on the primary and secondary stability of orthodontic mini-implants placed in a maxilla, to assess mini-implants failure rate (mini-implant loss) and to evaluate a pain level after the treatment. The randomized clinical split-mouth trial included 15 subjects, 30 implants (Dual Top Anchor System, Seoul, Korea) with a diameter 1.4mm and length of 10mm. Mini-implants were placed in the area of the attached gingiva between the second premolar and first molar teeth 2 mm below the mucogingival junction of both sides of the maxilla in 20 patients (13 women and 7 men; age: 32.5 ± 6.1 years).

02

Conditions studied

  • Malocclusion, Angle Class II

Keywords

  • ATP, biostimulation, micro-screw, Periotest, semiconductor laser
03

In context

Malocclusion

455 studies on the registry are indexed under Malocclusion; 89 are open to participants now.

This study's enrollment of 20 is below the median of 36 across 371 interventional studies indexed under Malocclusion.

Browse Malocclusion studies →

Lead sponsor

Wroclaw Medical University is the lead sponsor of 93 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • patients with class II malocclusion defect requiring lateral maxillary teeth distillation based on the use of orthodontic mini-implant;
  • the patients were treated first time using fixed orthodontic appliance;
  • no systemic diseases;
  • were not using anti-inflammatory drugs;

Exclusion criteria

Exclusion Criteria:

  • had used antibiotics in the previous 24 months;
  • smokers;
  • had history of radiotherapy,
  • taking bisphosphonate medication
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Right side of the maxilla

    The 635-nm laser parameters; dose: 10J per point (20J/cm2), time: 100 sec per point, 2 points (irradiation on a buccal, and a palatal side of the alveolus/implant), the total energy per session 20J.

    Procedure: Irradiation of implants with 635nm laser

  • No intervention
    Left side of the maxilla

Interventions

  • ProcedureIrradiation of implants with 635nm laser

    Irradiation of implants with 635nm laser with a dose of 10J

06

What researchers measure

Primary outcomes

  1. stability of orthodontic mini-implants

    The mini-implants stability was estimated employing a Periotest device (Medzintechnik Gulden e K, Modautal, Germany). The Periotest measurement system includes the sound formed from contact between an object and a metallic tapping bar in a handpiece, which is electromagnetically driven and electronically verified. The Periotest response detection is analyzed through a fast Fourier transform (FFT) algorithm. Simply put, the Periotest answer to tapping is estimated by an accelerometer and then analyzed. The signal generated by tapping is then transformed to a value called the Periotest value (PTV), which depends on the damping characteristics of the peri-implant tissue. \[27\] The Periotest Test values (PTVs) are based on a numerical scale ranging from -8 to +50, defined by mathematical computation. The lower Periotest values indicate higher implant stability and thereupon the higher absorption effect of the target objects.

    Time frame: 60 days

Secondary outcomes

  1. Pain level

    Immediately after the mini-implants placement, each patient received a questionnaire for individual pain assessment (the numeric rating scale, NRS-11, grade level 0-10). The maximum pain level was measured at both sides of the maxilla during the first day after the treatment. The NRS-11 scale consists of a conscious, subjective assessment of the pain experienced; therefore, it is used in the case of patients over ten years old. A rating of 0 signifies no pain, 1-3 represents mild pain, 4-6 moderate pain, and 7-10 severe pain.

    Time frame: 24 hours

  2. mini-implants loss

    Time frame: 60 days

07

Study locations

1 site
  • Private Dental Healtcare
    Wschowa, Poland
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04175405
Lead sponsor
Wroclaw Medical University
Responsible party
Jacek Matys (Principal Investigator, Wroclaw Medical University) — Principal investigator
First posted
Nov 25, 2019
Start date
Mar 6, 2019
Primary completion
Jun 2, 2019
Completion
Oct 24, 2019
Last update
Nov 25, 2019

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion